Abstract
Human Ia molecules were isolated from cells of LG-38, an HLA-homozygous lymphoid cell line of DR5 specificity. Three Ia subsets could be distinguished and separated by using specific alloantisera and a monoclonal antibody with polymorphic reactivity. These subsets carried the specificities DR5 and MT2, MT2 alone and MB3 alone. The structure of the three molecular species was analyzed by microfingerprinting. The subset carrying only MT2 was similar, in both the component α and β chains, to the major subset carrying DR5 and MT2, whereas the subset carrying MB3 was distinct in both chains from the other two subsets. These data are compatible with our previous findings obtained for the products of two Ia loci closely linked to the DR locus and provisionally called DC and BR; they also support the conclusion that the subset carrying only MT2 is an allelic product of the BR locus, whereas the MB3 subset is an allelic product of the DC locus. MT2 appears to be a shared specificity of DR and BR loci products.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allison, J. P., Walker, L. E., Russell, W. A., Pellegrino, M. A., Ferrone, S., Reisfeld, R. A., Frelinger, J. A., and Silver, J.: Murine Ia and human DR antigens: Homology of amino-terminal sequences. Proc. Natl. Acad. Sci. U.S.A. 75: 3953–3957, 1978
Bono, R. and Strominger, J.: Direct evidence of homology between human DC-1 antigen and murine I-A molecules NH2 terminal amino acid sequence analysis of human class II molecules carrying DC-1 and DR determinants. Nature 299: 836–838, 1982
Cook, R. G., Siegelman, M. S., Capra, J. D., Uhr, J. W., and Vitetta, E. S.: Structural studies on the murine alloantigens IV. NH2-terminal sequence analysis of allelic products of the I-A and. I-E/C subregions. J. Immunol. 122: 2232–2237, 1979
Corte, G., Calabi, F., Damiani, G., Bargellesi, A., Tosi, R., and Sorrentino, R.: Human Ia molecules carrying DC-1 determinant differ both in α- and β-subunits from la molecules carrying DR determinants. Nature 292: 357–360, 1981a
Corte, G., Damiani, G., Calabi, F., Fabbi, M., and Bargellesi, A.: Analysis of HLA-DR polymorphism by two-dimensional peptide mapping. Proc. Natl. Acad. Sci. U.S.A. 78: 534–538, 1981b
Duquesnoy, R. J. and Marrari, M.: MB system. In P. I. Terasaki (ed.): Histocompatibility Testing 1980, pp. 552–555, UCLA, Los Angeles, 1980
Duquesnoy, R. J., Marrari, M., and Annen, K.: Identification of an HLA-DR associated system of B cell alloantigens. Transplant. Proc. 11: 1757–1760, 1979
Feinstein, A., Richardson, N. E., and McIehinney, R. A. J.: Structure of lymphocyte membrane immunoglobulin. In B. Pernis and F. Vogel (ed.): Cells of Immunoglobulin Synthesis, pp. 165–181, 1979
Ferrara, G. B., Tosi, R., Longo, A., Castellani, A., Viviani, C., and Carminati, G.: A safe blood transfusion procedure for immunization against MH determinants in man. Transplantation 26: 150–152, 1978
Gefter, M. L., Margulies, D. H., and Scharff, M. D.: A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet.3: 231–236, 1977
Goyert, S. M., Shively, J. E., and Silver, J.: Biochemical characterization of a second family of human Ia molecules, HLA-DS, equivalent to murine I-A subregion molecules. J. Exp. Med. 550–566, 1982
Greenwood, F. C., Hunter, W. M., and Glover, J. S.: The preparation of 131-labeled human growth hormone of high specific radioactivity. Biochem. J. 89: 114–123, 1963
Karr, R. W., Kannapell, C. C., Stein, J. A., Gebel, H. M., Mann, D. L., Duquesnoy, R. J., Fuller, T. C., Rodey, G. E., and Schwartz, B. D.: Molecular relationships of the human B Cell alloantigens, MT2, MB3, MT4, and DR5. J. Immunol. 128: 1809–1818, 1982
Katagiri, M., Ikeda, H., Maruyama, N., Moriuchi, J., Wakisaka, A., Kimura, S., Aizawa, M., and Itakura, K.: Evidence for two B-cell alloantigen loci in the HLA-D region. Immunogenetics 9: 335–351, 1979
Kaufman, J. F., Anderson, R. L., and Strominger, J. L.: HLA-DR antigens have polymorphic light chains and invariant heavy chains as assessed by lysine-containing tryptic peptide analysis. J. Exp. Med. 152: 37s-53s, 1980
Koyama, K., Nakamuro, K., Tanigaki, N., and Pressman, D.: Alloantigens of human lymphoid cell lines; ‘human Ia-like antigens’. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay. Immunology 33: 217–230, 1977
Kratzin, H., Yang, C-Y, Getz, H., Pauly, E., Kolbel, S., Egert, G., Thinnes, R. P., Wernet, P., Altevogt, P., and Hilschmann, N.: Primary structure of class II human histocompatibility antigens. 1st communication: Amino acid sequence of the N-terminal 198 residues of the β chain of a HLA-Dw2,2; DR2,2-alloantigen. Hoppe-Seylers Z. Physiol. Chem. 362: 1665–1669, 1981
Laemmli, V. K.: Cleavage of structural proteins during the assembly of the bead of bacteriophage T4. Nature 227: 680–685, 1970
Legrand, L. and Dausset, J.: The complexity of the HL-A gene product. II. Possible evidence for a “public” determinant common to the 1st and 2nd genes. Transplantation 19: 177–180, 1975
McMillan, M., Cecka, J. M., Murphy, D. B., McDevitt, H. O., and Hood, L.: Partial amino acid sequences of murine Ia antigens of the I-ECd subregion. Immunogenetics 6: 137–147, 1978
Murphy, D. B. and Shreffler, D. C.: Cross-reactivity between H-2K and H-2D products. I. Evidence for extensive and reciprocal serological cross-reactivity. J. Exp. Med. 141: 374–391, 1975
Park, M. S., Terasaki, P. I., Nakata, S., and Aoki, D.: Supertypic DR groups: MT1, MT2, and MT3. In P. I. Terasaki (ed.): Histocompatibility Testing 1980, pp. 854–857, UCLA, Los Angeles 1980
Scalamogna, M., Mercurioli, F., Pizzi, C., and Sirechia, G.: Cross-reactivity between the first and second segregand series of the HLA system. Tissue Antigens 7: 125–127, 1976
Shackelford, D. A., Mann, D. L., van Rood, J. J., Ferrara, G. B., and Strominger, J. L.: Human B-cell alloantigen DC1, MT1, and LB/2 are identical to each other but distinct from the HLA-DR antigen. Proc. Natl. Acad. Sci. U.S.A. 78: 4566–4570, 1981
Silver, J. and Ferrone, S.: Structural polymorphism of human DR antigens. Nature 279: 436–437, 1979
Sorrentino, R., Corte, G., Calabi, F., Tanigaki, N., and Tosi, R.: A three loci model for the control of the small (β) subunit of human Ia molecules. In R. F. Revoltella, R. P. Revoltella, G. M. Pontieri, C. Basilico, G. Rovera, R. C. Gallo, and J. H. Subak-Sharpe (eds.) Expression of Differentiated Function in Cancer Cells, pp. 69–78, Raven Press, New York, 1982
Tanigaki, N. and Tosi, R.: The genetic control of human Ia alloantigens: A three-loci model derived from the immunochemical analysis of ‘supertypic’ specificities. Immunol. Rev. 66: 5–37, 1982a
Tanigaki, N. and Tosi, R.: Assessment of the specificity of human alloantisera and alloantigens by the use of radioiodinated human Ia antigens. Tissue Antigens 20: 1–21, 1982b
Tanigaki, N., Tosi, R., Pressman, D. and Ferrara, G. B.: Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus. Immunogenetics 10: 151–167, 1980
Tanigaki, N., Tosi, R., Centis, D., Ferrara, G. B., and Pressman, D.: Further characterization of two ‘DR rtypoid’ specificities. Additional evidence that they reside on molecules different from those carrying HLA-DR locus specificities. Hum. Immunol. 3: 93–108, 1981
Tanigaki, N., Tosi, R., Duquesnoy, R. J. and Ferrara, G. B.: Three Ia species with different structures and alloantigenic determinant in an HLA-homozygous cell line. J. Exp. Med. 231–247, 1983
Tosi, R., Tanigaki, N., Centis, D., Ferrara, G. B., and Pressman, D.: Immunological dissection of human Ia molecules. J. Exp. Med. 148: 1592–1611, 1978
Author information
Authors and Affiliations
Additional information
A unit of the New York State Department of Health.
Rights and permissions
About this article
Cite this article
Tanigaki, N., Tosi, R., Sagawa, K. et al. The distribution of DR5, MT2, and MB3 specificities on human Ia subsets. Immunogenetics 17, 371–386 (1983). https://doi.org/10.1007/BF00372456
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00372456